Methods of using substituted morpholine derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S237800

Reexamination Certificate

active

07812023

ABSTRACT:
The present invention relates to morpholine and thiomorpholine derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use.

REFERENCES:
patent: 5688792 (1997-11-01), Barbachyn et al.
patent: 2001/0049444 (2001-12-01), McNaughton-Smith
patent: 03175086 (1991-07-01), None
patent: WO 02/49628 (2002-06-01), None
patent: WO 02/66036 (2002-08-01), None
Main, M. J. et al., “Modulation of KCNQ2/3 Potassium Channels by the Novel Anticonvulsant Retigabine” Molecular Pharmacology, Baltimore, MD, USA, vol. 58, No. 2, Aug. 2000, pp. 253-262.
Database Beilstein Beilstein Crossfire Institut Zur Foerderung Der Chemischen Wissenschaften, DE, BRN 6233316 1993, XP002330358 abstract & Verma M AL: Arch Pharm (Weinheim W Ger), vol. 315, No. 7, 1962, pp. 356-363.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of using substituted morpholine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of using substituted morpholine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using substituted morpholine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4228961

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.